Hill-Rom® | Early Mobility | Physician Perspective – Dr. William Schweickert, U. Penn

April 24, 2016

Dr. William Schweickert of University of Pennsylvania, details the importance of early mobility in critically ill patients and how to bridge the implementation gap. He also summarizes findings from his recent work on the recent publication: A Survey Of International Practices And Infrastructure To Support Early Mobilization which showed that less than 30% of global ICU’s have a written early mobility protocol and known barriers can be overcome. He concludes with a proposed framework for early mobilization and practical advice to get started.

Spotlight

Lundbeck

Lundbeck is a global pharmaceutical company highly committed to improving the quality of life of people living with psychiatric and neurological disorders. For this purpose, Lundbeck is engaged in the research, development, production, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at disease areas such as depression, schizophrenia, Parkinson’s disease and Alzheimer’s disease. According to the World Health Organization, WHO, more than 700 million cases of psychiatric and neurological disorders are reported every year. These are serious and life-threatening diseases that affect the quality of life of the patients as well as of their relatives.

OTHER VIDEOS

Real time Chat API - How Telehealth is Transforming Healthcare Industry in the COVID-19 era

video | May 28, 2021

In a nutshell, telemedicine offers a far-reach and linking portal delivering convenience, profitability, and handy health-related information, actions, and predominant communication....

Watch Now

Home Health Manager with Bits In Glass

video | May 24, 2021

With home healthcare being more important than ever right now, see how Appian and our partner Bits In Glass brings real-time patient information to caregivers where they need it....

Watch Now

Determining Strategy and Success in Healthcare and Pharmaceutical Marketing

video | April 12, 2021

Hear from Coegi's trusted healthcare partner, PulsePoint, as their Chief Strategy Officer Chris Neuner discusses digital marketing is critical to enhance patient and physician education and ultimately drive better health outcomes....

Watch Now

UpLyft Caregiver Injury

video | December 08, 2020

Many caregivers change professions due to injuries, but whether they do or not, there are several consequences.First is the pain resulting from the injury, and with that often comes the hardships and the inconveniences that accompany treating and recovering from these injuries. This can be expensive in two ways: the treatment itself and, when the injury is severe enough to keep the caregiver from work, loss of income....

Watch Now

Spotlight

Lundbeck

Lundbeck is a global pharmaceutical company highly committed to improving the quality of life of people living with psychiatric and neurological disorders. For this purpose, Lundbeck is engaged in the research, development, production, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at disease areas such as depression, schizophrenia, Parkinson’s disease and Alzheimer’s disease. According to the World Health Organization, WHO, more than 700 million cases of psychiatric and neurological disorders are reported every year. These are serious and life-threatening diseases that affect the quality of life of the patients as well as of their relatives.

Events